Skip to main content

Table 1 Variables of CHD risk equation used in model base case

From: Improvement of long-term risks of cardiovascular events associated with community-based disease management in Chinese patients of the Xinjiang autonomous region of China

 

Male

Female

Coefficient

Coefficient

Age

0.07

0.07

SBP - optimal

−0.51

−0.5

SBP – normal

Reference

Reference

SBP – high normal

0.21

−0.87

SBP – stage 1 hypertension

0.33

0.34

SBP – stage 2–4 hypertension

0.77

0.47

Total cholesterol < 160 mg/dL

−0.51

0.18

Total cholesterol 160–199 mg/dL

Reference

Reference

Total cholesterol 200–239 mg/dL

0.07

0.13

Total cholesterol 240–279 mg/dL

0.32

0.14

Total cholesterol ≥ 280 mg/dL

0.52

1.67

HDL-C < 35 mg/dL

−0.25

0.62

HDL-C 35–44 mg/dL

0.01

0.3

HDL-C 45–49 mg/dL

Reference

0.08

HDL-C 50–59 mg/dL

−0.07

Reference

HDL-C ≥ 60 mg/dL

−0.4

−0.78

Diabetes (yes = 1, no = 0)

0.09

0.18

Smoking (yes = 1, no = 0)

0.62

− 0.95

Survival

0.9895

0.9961

  1. CHD coronary heart disease, HDL-C high-density lipoprotein cholesterol, SBP systolic blood pressure
  2. SBP optimal: ≤120 mmHg; SBP normal 120–130 mmHg; SBP high normal 130–140 mmHg; SBP stage 1 hypertension 140–160 mmHg; SBP stage 2–4 hypertension ≥160 mmHg